Table 4 Risk assessment for ROP by a logistic regression analysis
From: Aerosol therapy in relation to retinopathy of prematurity in mechanically ventilated preterm infants
Risk factor | OR | 95% CI | p value |
|---|---|---|---|
Male | 0.592 | 0.301~1.165 | 0.129 |
Aerosol therapy | 2.828 | 1.069~7.484 | 0.036 |
iNO | 2.084 | 0.585~7.426 | 0.257 |
GA (week) | |||
24~25 | 4.001 | 1.518~10.55 | 0.005 |
26~27 | 3.920 | 1.688~9.104 | 0.001 |
28~29 | reference | ||
Duration of HFV (day) | |||
> 28 | 1.610 | 0.566~4.580 | 0.372 |
8 ~ 28 | 2.111 | 0.719~6.197 | 0.174 |
1 ~ 7 | 1.823 | 0.763~4.357 | 0.177 |
Never use | reference | ||
Duration of intubation (day) | |||
> 84 | 1.971 | 0.569~6.832 | 0.285 |
43 ~ 84 | 1.224 | 0.342~4.373 | 0.756 |
22 ~ 42 | 0.838 | 0.311~2.259 | 0.726 |
8 ~ 21 | reference | ||